ENDOMETRIAL HYPERPLASIA IN AN OOPHORECTOMIZED WOMAN RECEIVING TAMOXIFEN THERAPY - CASE-REPORT

被引：41

作者：

CROSS, SS ^{[1
]}

ISMAIL, SM ^{[1
]}

机构：

[1] UNIV COLL CARDIFF,DEPT PATHOL,CARDIFF CF4 4XN,S GLAM,WALES

来源：

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1990年 / 97卷 / 02期

关键词：

D O I：

10.1111/j.1471-0528.1990.tb01748.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：190 / 192

页数：3

共 8 条

[1] BOCCARDO F, 1981, ONCOLOGY, V38, P281, DOI 10.1159/000225571
[2] FORNANDER T, 1989, LANCET, V1, P117
[3] EFFECT OF ANTI-OESTROGEN TAMOXIFEN ON PLASMA-LEVELS OF LUTEINIZING-HORMONE, FOLLICLE-STIMULATING-HORMONE, PROLACTIN, ESTRADIOL AND PROGESTERONE IN NORMAL PREMENOPAUSAL WOMEN
GROOM, GV
GRIFFITHS, K
[J]. JOURNAL OF ENDOCRINOLOGY, 1976, 70 (03) : 421 - 428
[4] HENDRICKSON M, 1980, MAJOR PROBLEMS PATHO, V12, P285
[5] KILLACKEY MA, 1985, CANCER TREAT REP, V69, P237
[6] KURMAN RJ, 1987, BLAUSTEINS PATHOLOGY, P34
[7] NEUMANNOVA M, 1985, OBSTET GYNECOL, V66, P695
[8] ENDOCRINE CONSEQUENCES OF CONTINUOUS ANTI-ESTROGEN THERAPY WITH TAMOXIFEN IN PREMENOPAUSAL WOMEN
SHERMAN, BM
CHAPLER, FK
CRICKARD, K
WYCOFF, D
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (02) : 398 - 404